Heregulin, a new interactor of the telosome/shelterin complex in human telomeres
- ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism & Cancer Group, Catalan Institute of Oncology (ICO), Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Spain; DOE/OSTI
- Evanston Northwestern Healthcare Research Institute, Evanston, IL, USA
- IBYME, CONICET-Laboratorio de Immunohematología, Buenos Aires, Argentina
- Laboratory of Hematology Service, Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Department of Biochemistry, University of Mississippi, Jackson, MS, USA; Cancer Institute, University of Mississippi, Jackson, MS, USA
- Lawrence Berkeley National Laboratory, Life Sciences Division, Berkeley, CA, USA; Buck Institute for Research on Aging, Novato, CA, USA
- Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA; Mayo Clinic Cancer Center, Rochester, MN, USA
Telomere length, shape and function depend on a complex of six core telomere-associated proteins referred to as the telosome or shelterin complex. We here demonstrate that the isoform β2 of the heregulin family of growth factors (HRGβ2) is a novel interactor of the telosome/shelterin complex in human telomeres. Analysis of protein-protein interactions using a high-throughput yeast two-hybrid (Y2H) screen identified RAP1, the only telomere protein that is conserved from yeasts to mammals, as a novel interacting partner of HRGβ2. Deletion analysis of RAP1 revealed that the linker domain, a region previously suggested to recruit negative regulators of telomere length, interacts specifically with HRGβ2. Co-immunoprecipitation and imaging experiments demonstrated that, in addition to RAP1, HRGβ2 could associate with the RAP1-associated telomeric repeat binding factor 2 (TRF2). Deletion analysis of HRGβ2 confirmed that a putative nuclear localization signal (NLS) was necessary for nuclear HRGβ2 to exert a negative regulation of telomere length whereas the N-terminus (extracellular) amino acids of HRGβ2 were sufficient to interact with RAP1/TRF2 and promote telomere shortening. Taken together, our studies identify nuclear HRGβ2 as one of the previously unknown regulators predicted to be recruited by the RAP1 linker domain to negatively regulate telomere length in human cells. Our current findings reveal that a new, but likely not the last, unexpected visitor has arrived to the “telosome/shelterin town”.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE
- Grant/Contract Number:
- AC03-76SF00098
- OSTI ID:
- 1627986
- Journal Information:
- Oncotarget, Journal Name: Oncotarget Journal Issue: 37 Vol. 6; ISSN 1949-2553
- Publisher:
- Impact JournalsCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Heterogeneous Nuclear Ribonucleoproteins Involved in the Functioning of Telomeres in Malignant Cells
|
journal | February 2019 |
Similar Records
Heregulin, a new regulator of telomere length in human cells
Journal Article
·
Tue Jul 21 20:00:00 EDT 2015
· Oncotarget
·
OSTI ID:1627987